Modeling of novel CDK7 inhibitors activity by molecular dynamics and free energy perturbation methods Full article
| Journal |
Mendeleev Communications
ISSN: 1364-551X , E-ISSN: 0959-9436 |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Output data | Year: 2020, Volume: 30, Number: 4, Pages: 430-432 Pages count : 3 DOI: 10.1016/j.mencom.2020.07.008 | ||||||||
| Authors |
|
||||||||
| Affiliations |
|
Abstract:
Although CDK7 inhibitors are considered to be potential anticancer drugs, all inhibitors developed so far have significant disadvantages preventing their further use. We have developed a new CDK7 inhibitor scaffold lacking hepatotoxicity using molecular dynamics (MD) and free energy perturbation (FEP/MD) methods, and were able to double its binding affinity after additional research. The combination of MD and FEP/MD methods was shown to be a valuable instrument for the development of novel and potent CDK7 inhibitors for anticancer therapy.
Cite:
Rusina P.V.
, Titov I.Y.
, Panova M.V.
, Stroylov V.S.
, Abdyusheva Y.R.
, Murlatova E.Y.
, Svitanko I.V.
, Novikov F.N.
Modeling of novel CDK7 inhibitors activity by molecular dynamics and free energy perturbation methods
Mendeleev Communications. 2020. V.30. N4. P.430-432. DOI: 10.1016/j.mencom.2020.07.008 WOS Scopus OpenAlex
Modeling of novel CDK7 inhibitors activity by molecular dynamics and free energy perturbation methods
Mendeleev Communications. 2020. V.30. N4. P.430-432. DOI: 10.1016/j.mencom.2020.07.008 WOS Scopus OpenAlex
Identifiers:
| Web of science: | WOS:000557884000008 |
| Scopus: | 2-s2.0-85088971592 |
| OpenAlex: | W3047505945 |